Dublin, April 20, 2022 (GLOBE NEWSWIRE) -- The "Next-generation Diagnostics Outlook, 2022" report has been added to ResearchAndMarkets.com's offering.
In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testing.
With the arrival of blood-based assays for chronic disease screening and next-generation molecular and point-of-care diagnostics for COVID-19-related testing, the global market grew 15.5% in 2021. Digital health solutions (patient portal + mobile app) facilitate a dramatic shift in care delivery from traditional to alternative sites, simplifying accessibility of diagnostic tests, and delivering an automated testing experience for labs to ensure rapid scalability. Patients have greater access control/faster turnaround time to results; providers can triage patients quickly through an efficient and connected workflow.
An accelerated approval pathway would foster rapid development over the next few years. The increase in availability of home care kits, spike in demand for assays and consumables, compactness of devices, and automation of workflows to serve a broad spectrum of settings are growth vectors. Early detection to initiate optimal treatment plans is a paradigm shift in personalized care.
The outlook report forecasts revenue for molecular diagnostics, point-of-care testing, clinical chemistry and immunoassays. It considers strategic imperatives, macroeconomic trends, and growth opportunities, and presents 5 predictions for 2022.
Key Topics Covered:
1. Strategic Imperatives
2. Analysis Highlights
2021 Revenue Breakdown
Top Predictions for 2022
3. Growth Environment
4. Macroeconomic Factors
Global GDP Growth
2022 Global GDP Growth Snapshot
Supply Chain Disruptions Impact Analysis
Accessibility Initiatives Impact Analysis
5. Revenue Trends, 2022
Revenue Forecast by Segment
6. Top 5 Predictions, 2022
7. Segment Outlook, 2022
Clinical Chemistry and Immunoassays Market Snapshot
Molecular Diagnostics Market Snapshot
POCT Market Snapshot
In Vitro Diagnostics Companies to Watch
8. Growth Opportunity Universe
Growth Opportunity 1 - Liquid Biopsy as a Biomarker-driven Tool for Precision Oncology
Growth Opportunity 2 - Decentralized and Point-of-Care Molecular Testing for Infectious Disease
Growth Opportunity 3 - Smart Labs as a Service for the Digital Transformation of Diagnostic Laboratories
10. Next Steps
11. List of Exhibits
For more information about this report visit https://www.researchandmarkets.com/r/yg43c
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900